How Decriminalizing Drugs Might Affect the Spread of HIV in Tijuana

Richard Branson and experts debate the losing war on drugs — and its victims — at UC San Diego event —

As the 1960s came to a close, Richard Nixon famously declared a “war on drugs.” They were “public enemy number one,” the president said. Their menace demanded a full-throated federal effort of interdiction, eradication and incarceration.

The goal: No more illegal drugs. Period.

The reality: The war still rages. There are now more illegal drugs produced and consumed than ever.

If the war on drugs were one of his businesses, said Sir Richard Branson, the renowned British magnate, philanthropist and activist, it would have been shut down within a year. “It hasn’t worked at all, ever, but governments continue to ignore the facts, creating untold misery. Drug use isn’t a criminal problem. It’s a health problem.”

Branson, who has become a major voice in the global drug policy debate, visited UC San Diego last week to participate in a panel discussion on global drug decriminalization and Tijuana’s HIV/AIDS epidemic, which is fueled in part by widespread drug use, notably the sharing of needles to inject black tar heroin. … Read the Full Feature Story from the UC San Diego Newsroom

Steffanie Strathdee, PhD

Steffanie Strathdee, PhD

The UC San Diego Global Health Institute (GHI) was a co-sponsor of the event. GHI Director Steffanie Strathdee, PhD, was moderator and host of the event.

Dr. Strathdee is Associate Dean of Global Health Sciences, Harold Simon Professor and Chief of the Division of Global Public Health in the Department of Medicine.

UC San Diego Researcher Receives $2.5 million Award from the National Institute on Drug Abuse

Davey Smith, MD, associate professor of medicine in the Division of Infectious Diseases at the University of California, San Diego School of Medicine and the VA San Diego Health System is one of three recipients of the 2012 Avant-Garde Award for HIV/AIDS research. This prestigious award, announced today by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of HIV/AIDS in drug abusers. … Read the full story from the UCSD Newsroom

David M. Smith, MD, MASDavey M. Smith, MD, MAS, is a physician-scientist specializing in the study of HIV transmission. He directs the Translational Virology Core at the Center for AIDS Research and the Early Intervention Program at the Antiviral Research Center at UCSD.Dr. Smith received his internal medicine residency training, including a year as chief medical resident, and his fellowship training in infectious diseases at UCSD. He earned his Masters of Advanced Studies (MAS) degree in clinical research at UCSD as well.

More about Dr. Smith’s work:

More about the award: